Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 9/2008

01.09.2008 | Review Article

A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants

verfasst von: Lene Thorsen, Kerry S. Courneya, Clare Stevinson, Sophie D. Fosså

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

We reviewed physical activity (PA) studies in prostate cancer (PC) survivors investigating (a) the effects of PA on health outcomes, (b) the prevalence of PA, and (c) the determinants of PA.

Materials and methods

A systematic search of the literature identified nine studies on the outcomes of PA, six studies on the prevalence of PA, and four studies on the determinants of PA in PC survivors.

Results

Results showed promising effects of PA on muscular fitness, physical functioning, fatigue, and health-related quality of life. The prevalence of PA varied widely from <30% to >70%, depending on the type of measure used. PA in PC survivors was predicted by motivational variables such as intentions, perceived behavioral control, and subjective norms.

Conclusion

Although preliminary research is promising, there remains a significant amount of research to be done on the role of PA in PC survivors. Moreover, future research would benefit from larger samples using randomized controlled trial methodology.
Literatur
1.
Kruger J (2007) Prevalence of regular physical activity among adults—United States, 2001 and 2005. MMWR Morb Mortal Wkly Rep 56:1209–1212
2.
Anderson LA, Ballew CC, Berryman JW, Brawley LR, Brown DR, Caplan LS, Coates RJ, Crespo CJ, DiPietro L, Dishman RK, Engelgau MM, Ettinger WH, Freedman DS, Fridinger F, Heath GW, Holmes WA, Howze EH, Kann LK, King AC, Kohl HW, Koplan JP, Kriska AM, Latham BD, Lee I, Lloyd E, Marcus BH, Matson-Koffman D, Nadel MR, Obarzanek E, Plepys CM, Pollock ML, Pratt M, Raford PT, Rejeski WJ, Rothenberg RB, Serdula MK, Schoenborn CA, Simons-Morton DG, Stone EJ, Tappe MK, Taylor WC, Warren CW, Young DR (1996) Physical activity and health: a report of the surgeon general. In: Blair SN, Franks AL, Shelton DM, Livengood JR, Hull FL, Breedlove B (eds) U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA Ref type: report
3.
Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ (2005) Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from capsure. Urology 66:1060–1065PubMedCrossRef
4.
Bellizzi KM, Rowland JH, Jeffery DD, McNeel T (2005) Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 23:8884–8893PubMedCrossRef
5.
Berruti A, Dogliotti L, Terrone C, Cerutti S, Isaia G, Tarabuzzi R, Reimondo G, Mari M, Ardissone P, De LS, Fasolis G, Fontana D, Rossetti SR, Angeli A (2002) Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J Urol 167:2361–2367PubMedCrossRef
6.
Blanchard CM, Courneya KS, Rodgers WM, Murnaghan DM (2002) Determinants of exercise intention and behavior in survivors of breast and prostate cancer: an application of the theory of planned behavior. Cancer Nurs 25:88–95PubMedCrossRef
7.
Blanchard CM, Stein KD, Baker F, Dent MF, Denniston MM, ourneya KS, Nehl E (2004) Association between current lifestyle behaviors and health-related quality of life in breast, colorectal, and prostate cancer survivors. Psychol Health 19:1–13CrossRef
8.
Carmack Taylor CL, Demoor C, Smith MA, Dunn AL, Basen-Engquist K, Nielsen I, Pettaway C, Sellin R, Massey P, Gritz ER (2006) Active for life after cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients. Psychooncology. 15:847–862PubMedCrossRef
9.
Conn VS, Hafdahl AR, Porock DC, McDaniel R, Nielsen PJ (2006) A meta-analysis of exercise interventions among people treated for cancer. Support Care Cancer 14:699–712PubMedCrossRef
10.
Coups EJ Ostroff JS (2005) A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med 40:702–711CrossRef
11.
Courneya KS (2003) Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc 35:1846–1852PubMedCrossRef
12.
Courneya KS, Blanchard CM, Laing DM (2001) Exercise adherence in breast cancer survivors training for a dragon boat race competition: a preliminary investigation. Psychooncology 10:444–452PubMedCrossRef
13.
Courneya KS, Keats MR, Turner AR (2000) Social cognitive determinants of hospital-based exercise in cancer patients following high dose chemotherapy and bone marrow transplantation. Int J Behav Med 7:189–203CrossRef
14.
Courneya KS, Segal RJ, Reid RD, Jones LW, Malone SC, Venner PM, Parliament MB, Scott CG, Quinney HA, Wells GA (2004) Three independent factors predicted adherence in a randomized controlled trial of resistance exercise training among prostate cancer survivors. J Clin Epidemiol 57:571–579PubMedCrossRef
15.
Culos-Reed SN, Robinson JL, Lau H, O'Connor K, Keats MR (2007) Benefits of a physical activity intervention for men with prostate cancer. Journal of Sport & Exercise Psychology 29:118–127
16.
da Silva FC, Fossa SD, Aaronson NK, Serbouti S, Denis L, Casselman J, Whelan P, Hetherington J, Fava C, Richards B, Robinson MR (1996) The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853. Eur J Cancer 32:72–77CrossRef
17.
Dahn JR, Penedo FJ, Molton I, Lopez L, Schneiderman N, Antoni MH (2005) Physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy. Urology 65:953–958PubMedCrossRef
18.
Demark-Wahnefried W, Clipp EC, Morey MC, Pieper CF, Sloane R, Snyder DC, Cohen HJ (2004) Physical function and associations with diet and exercise: results of a cross-sectional survey among elders with breast or prostate cancer. Int J Behav Nutr Phys Act 1:16PubMedCrossRef
19.
Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E (2000) Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88:674–684PubMedCrossRef
20.
Diamond TH, Bucci J, Kersley JH, Aslan P, Lynch WB, Bryant C (2004) Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy. J Urol 172:529–532PubMedCrossRef
21.
Galvao DA, Newton RU (2005) Review of exercise intervention studies in cancer patients. J Clin Oncol 23:899–909PubMedCrossRef
22.
Galvao DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, Suzuki K, Yamaya K, Newton RU (2006) Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 38:2045–2052PubMedCrossRef
23.
Hatano T, Oishi Y, Furuta A, Iwamuro S, Tashiro K (2000) Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer. BJU Int 86:449–452PubMedCrossRef
24.
Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486PubMedCrossRef
25.
Hunt-Shanks TT, Blanchard CM, Baker F, Hann D, Roberts CS, McDonald J, Livingston M, Witt C, Ruiterman J, Ampela R, Kaw OC (2006) Exercise use as complementary therapy among breast and prostate cancer survivors receiving active treatment: examination of exercise intention. Integr Cancer Ther 5:109–116PubMedCrossRef
26.
Kirshbaum MN (2007) A review of the benefits of whole body exercise during and after treatment for breast cancer. J Clin Nurs 16:104–121PubMedCrossRef
27.
Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 23:3830–3842PubMedCrossRef
28.
Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC (1994) Quality of life of patients with prostate cancer and their spouses: the value of a data base in clinical care. Cancer 73:2791–2802PubMedCrossRef
29.
Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q, Botteman M, Litwin MS (2004) Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer 101:541–549PubMedCrossRef
30.
Kuhn KG, Boesen E, Ross L, Johansen C (2005) Evaluation and outcome of behavioural changes in the rehabilitation of cancer patients: a review. Eur J Cancer 41:216–224PubMedCrossRef
31.
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH (1995) Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273:129–135PubMedCrossRef
32.
McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 175:34–41PubMed
33.
Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS (2006) Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24:3527–3534PubMedCrossRef
34.
Mittan D, Lee S, Miller E, Perez RC, Basler JW, Bruder JM (2002) Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 87:3656–3661PubMedCrossRef
35.
Oliver SJ (2003) Physiological and psychological effects of progressive resistance training in elderly prostate cancer patients undergoing androgen deprivation therapy: a pilot study. University of Wales, Bangor, UK Ref type: thesis/dissertation
36.
Ott C, Fulton MK (2005) Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer. J Am Acad Nurse Pract 17:113–122PubMedCrossRef
37.
Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF (2007) On the importance of race, socioeconomic status, and comorbidity when evaluating quality of life in men with prostate cancer. J Urol 177:1992–1999PubMedCrossRef
38.
39.
Pinto BM, Maruyama NC (1999) Exercise in the rehabilitation of breast cancer survivors. Psychooncology 8:191–206PubMedCrossRef
40.
Pirl WF, Siegel GI, Goode MJ, Smith MR (2002) Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psychooncology 11:518–523PubMedCrossRef
41.
Preston DM, Torrens JI, Harding P, Howard RS, Duncan WE, McLeod DG (2002) Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. Prostate Cancer Prostatic Dis 5:304–310PubMedCrossRef
42.
Rosenblatt DE, Mellow A (1995) Depression during hormonal treatment of prostate cancer. J Am Board Fam Pract 8:317–320PubMed
43.
Schmitz KH, Holtzman J, Courneya KS, Masse LC, Duval S, Kane R (2005) Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 14:1588–1595PubMedCrossRef
44.
Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21:1653–1659PubMedCrossRef
45.
Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD, Cockcroft JR, Scanlon MF, Davies JS (2001) The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 86:4261–4267PubMedCrossRef
46.
Smith MR (2004) Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 63:742–745PubMedCrossRef
47.
Tayek JA, Heber D, Steiner B, Rajfer J, Swerdloff RS (1990) Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism 39:1314–1319PubMedCrossRef
48.
Windsor PM, Nicol KF, Potter J (2004) A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101:550–557PubMedCrossRef
49.
Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C (2007) Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39:1435–1445PubMedCrossRef
Metadaten
Titel
A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants
verfasst von
Lene Thorsen
Kerry S. Courneya
Clare Stevinson
Sophie D. Fosså
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2008
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0411-7

Weitere Artikel der Ausgabe 9/2008

Supportive Care in Cancer 9/2008 Zur Ausgabe

Original Article

Patient–oncologist communication in advanced cancer: predictors of patient perception of prognosis

Original Article

Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report

Original Article

The acute effect of tropisetron on ECG parameters in cancer patients

Original Article

Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders

Original Article

The use and toxicity of steroids in the management of patients with brain metastases

Short Communication

Development of a score that predicts survival among patients with bone metastasis revealing solid tumor

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise